ALMAC
Almac has been supplying peptides to the research community and for clinical trials for 30 years. The field of personalized cancer vaccines required a new manufacturing paradigm to ensure high-throughput manufacture of multiple neoantigens in an appropriate timescale to the required quality and regulatory standards. Almac has created a world-leading offering to meet all of those demands, which can be tailored to meet specific client needs. Think Almac for peptide excellence.
